美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 70 条
共 4 页，当前第 4 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| OXALIPLATIN |
091358 |
003 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
200MG/40ML (5MG/ML) |
No
|
No
|
2017/11/14
|
2017/11/14
|
MYLAN LABS LTD |
Discontinued |
| OXALIPLATIN |
204880 |
001 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
50MG/10ML (5MG/ML) |
No
|
No
|
2018/03/05
|
2018/03/05
|
ACTAVIS |
Prescription |
| OXALIPLATIN |
204880 |
002 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
100MG/20ML (5MG/ML) |
No
|
No
|
2018/03/05
|
2018/03/05
|
ACTAVIS |
Prescription |
| OXALIPLATIN |
207562 |
001 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
50MG/10ML (5MG/ML) |
No
|
No
|
2018/10/16
|
2018/10/16
|
NOVAST LABS |
Prescription |
| OXALIPLATIN |
207562 |
002 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
100MG/20ML (5MG/ML) |
No
|
No
|
2018/10/16
|
2018/10/16
|
NOVAST LABS |
Prescription |
| OXALIPLATIN |
202922 |
001 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
50MG/10ML (5MG/ML) |
No
|
No
|
2019/02/15
|
2014/04/08
|
SUN PHARM |
Discontinued |
| OXALIPLATIN |
202922 |
002 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
100MG/20ML (5MG/ML) |
No
|
No
|
2019/02/15
|
2014/04/08
|
SUN PHARM |
Discontinued |
| OXALIPLATIN |
202922 |
003 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
200MG/40ML (5MG/ML) |
No
|
No
|
2019/02/15
|
2019/02/15
|
SUN PHARM |
Discontinued |
| OXALIPLATIN |
217348 |
001 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
50MG/10ML (5MG/ML) |
No
|
No
|
2024/01/11
|
2024/01/11
|
MEITHEAL |
Prescription |
| OXALIPLATIN |
217348 |
002 |
ANDA |
OXALIPLATIN |
INJECTABLE;INTRAVENOUS |
100MG/20ML (5MG/ML) |
No
|
No
|
2024/01/11
|
2024/01/11
|
MEITHEAL |
Prescription |